Tanriover, M. D. Et Al. 2021. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.. Lancet (London, England) , vol.398, no.10296 , 213-222.

Tanriover, M. D., Doğanay, H. L., Akova, M., Güner, H. R., Azap, A., Akhan, S., ... Köse, Ş.(2021). Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.. Lancet (London, England) , vol.398, no.10296, 213-222.

Tanriover, Mine Et Al. "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.," Lancet (London, England) , vol.398, no.10296, 213-222, 2021

Tanriover, Mine D. Et Al. "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.." Lancet (London, England) , vol.398, no.10296, pp.213-222, 2021

Tanriover, M. D. Et Al. (2021) . "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.." Lancet (London, England) , vol.398, no.10296, pp.213-222.

@article{article, author={Mine Durusu Tanriover Et Al. }, title={Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.}, journal={Lancet (London, England)}, year=2021, pages={213-222} }